Skip to content

Evaluation of the effect of ghamz with needle on improvement of respiratory symptoms of COVID-19 patients admitted to hospital

Evaluation of the effect of ghamz with needle, based on the knowledge of Persian medicine on improvement of respiratory symptoms of COVID-19 patients admitted to hospital

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150825023753N17
Enrollment
18
Registered
2020-11-01
Start date
2020-04-13
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus infection. Coronavirus infection, unspecified

Interventions

Intervention 1: Intervention group: In intervention group ghamz with needle will be performed at six points LU5, LU7 and SP6, symmetrically on both sides of the body, (points 5 and 7 of the lung path

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: The patient's coronavirus is approved by PCR test The patient is hospitalized. The patient agrees to participate in the study The respiratory rate of the patient is more than 30 times per minute Blood oxygen level should be less than 93% The patient have pulmonary infiltration according to chest x-ray graph The patient does not afflict from any serious simultaneous heart, lung, brain, and endocrine disease The patient's ability and personal desire to fill out a personal consent form to enter the study

Exclusion criteria

Exclusion criteria: The patient suffers from any serious concomitant diseases of the heart, lungs, brain, glands Patient dissatisfaction with participation in the study Pregnant and lactating mothers Existence of any conditions in the patient that, according to the physician's judgment, prevent the continuation of the treatment intervention Resistant hypoxemia Hemodynamic instability Hypercapnia

Design outcomes

Primary

MeasureTime frame
Respiratory rate per minutes. Timepoint: Daily. Method of measurement: Using a vital signs monitoring device (heart monitoring).;Percentage of blood oxygen saturation. Timepoint: Daily. Method of measurement: Pulse oximeter device.;Cough. Timepoint: Daily. Method of measurement: Visual Analogue Scale (VAS).;Dyspnea. Timepoint: Daily. Method of measurement: Visual Analogue Scale (VAS).;Body temperature (fever). Timepoint: Daily. Method of measurement: Thermometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Amir Mohammad Jaladat

Shiraz University of Medical Sciences

drjaladat@gmail.com+98 71 3234 9983

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026